Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study
Authors:
Open Access
- 9 December 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (49) , e32217
Abstract
The prognosis of metastatic lung adenocarcinoma (MLUAD) varies greatly. At present, no studies have constructed a satisfactory prognostic model for MLUAD. We identified 44,878 patients with MLUAD. The patients were randomized into the training and validation cohorts. Cox regression models were performed to identify independent prognostic factors. Then, R software was employed to construct a new nomogram for predicting overall survival (OS) of patients with MLUAD. Accuracy was assessed by the concordance index (C-index), receiver operating characteristic curves and calibration plots. Finally, clinical practicability was examined via decision curve analysis. The OS time range for the included populations was 0 to 107 months, and the median OS was 7.00 months. Nineteen variables were significantly associated with the prognosis, and the top 5 prognostic factors were chemotherapy, grade, age, race and surgery. The nomogram has excellent predictive accuracy and clinical applicability compared to the TNM system (C-index: 0.723 vs 0.534). The C-index values were 0.723 (95% confidence interval: 0.719–0.726) and 0.723 (95% confidence interval: 0.718–0.729) in the training and validation cohorts, respectively. The area under the curve for 6-, 12-, and 18-month OS was 0.799, 0.764, and 0.750, respectively, in the training cohort and 0.799, 0.762, and 0.746, respectively, in the validation cohort. The calibration plots show good accuracy, and the decision curve analysis values indicate good clinical applicability and effectiveness. The nomogram model constructed with the above 19 prognostic factors is suitable for predicting the OS of MLUAD and has good predictive accuracy and clinical applicability.Keywords
This publication has 36 references indexed in Scilit:
- Nomogram: An analogue tool to deliver digital knowledgeThe Journal of Thoracic and Cardiovascular Surgery, 2018
- Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)JNCI: Journal of the National Cancer Institute, 2018
- Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood CharacteristicsJournal of Clinical Oncology, 2018
- Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysisLung Cancer, 2018
- Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectJNCI: Journal of the National Cancer Institute, 2017
- The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2017
- Risk of cardiac death among cancer survivors in the United States: a SEER database analysisExpert Review of Anticancer Therapy, 2017
- Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional RegistryJournal of Clinical Oncology, 2017
- Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2015
- Metastatic sites and survival in lung cancerLung Cancer, 2014